Navigation Links
Differential Gene Expression Analysis of Pure Cell Populations from Frozen UterineTissue Using Laser Capture Microdissection (LCM) and cDNA Microarrays

Se-Jin Yoon and Kyung-Ah Lee Infertility Medical Center, CHA General Hospital, Seoul 135-081, Korea

Laser Capture Microdissection (LCM) is an innovative technique which permits the rapid and reliable procurement of pure cell populations from heterogeneous tissue sections. After LCM, RNA isolated from pure cell populations was amplified to generate adequate amounts of antisense RNA (aRNA) for hybridization, and the differential gene expression profiles were analyzed between two experimental groups.

When investigating molecular mechanisms in specific tissues or cells, the accuracy of deduced mechanisms often depends on the relative abundance of the cell population in question. Mammalian uterine tissue consists of endometrium and myometrium. The endometrium is comprised of luminal epithelium, densely packed stroma, and the germinal basalis. For implantation, blastocysts make their first physical uterine contact with the maternal endometrial luminal epithelium. In previous analyses of global gene expression during implantation, authors used whole uterine tissue, thus these studies produced information on the temporal gene expression profile in the uterus, but not in the specific cell population.1,2 Using LCM, a pure population of luminal epithelial tissue was obtained, without stromal cell or embryonic contamination, with the objective of identifying genes expressed exclusively in the luminal epithelium during the apposition stage of implantation. Total cellular RNA was then amplified to obtain aRNA for microarray hybridization to elucidate genes differentially expressed in the luminal epithelium of implantation (IM) sites compared to the interimplantation (INTER) sites (no blastocyst implantation).3


1. Freshly frozen tissues were cut into 5 m thick sections and placed ont o plain glass slides. Slides were stored at -70 oC until use.
NOTE: Slides may be stored at -70oC for up to six months.

2. Slides were stained with hematoxylin and eosin, and dehydrated per the following protocol.
1) Defrost slides briefly, 30 seconds or less.
2) Fix with 70% ethanol for 30 seconds
3) Wash with DEPC-treated distilled water for 30 seconds.
4) Stain with Mayers hematoxylin (DAKO, Cat. # S3309) for 30 seconds.
5) Wash with DEPC-treated distilled water for 30 seconds.
6) Wash with Bluing reagent (1X Scotts tap water; Sigma, Cat. # S5134) for 30 seconds.
7) Dehydrate with 70% ethanol for 30 seconds.
8) Dehydrate with 95% ethanol for 30 seconds.
9) Stain with Eosin (Sigma, Cat. # E6003) for 30 seconds.
10) Place the slides to 75% ethanol for 30 seconds.
11) Place the slides to 95% ethanol for 30 seconds.
12) Place the slides to 100% ethanol for 30 seconds.
13) Place the slides to xylene for 5 minutes.
14) Remove slides from xylene and air dry for 5 minutes.

LCM was performed using a PixCell II system (Arcturus, Cat# LCM1106) using CapSure Macro LCM caps (Arcturus, Cat# LCM0211). Pure luminal epithelium of implantation or interimplantation sites was isolated using LCM (Figure 1A), filling an entire CapSure Macro cap with cells of interest.

1. Total cellular RNA was extracted from captured cells immediately after microdissection using the PicoPure RNA Isolation Kit (Arcturus, Cat. # KIT0202).
a) 50 l extraction buffer was pipetted into a 0.5 ml microcentrifuge tube.
b) Placed the CapSure caps carrying the captured cells onto the microcentrifuge tube and invert ed the assembly such that the extraction buffer completely covered the cap surface.
c) Incubated at 42oC for 30min.
d) Performed RNA binding onto the silica column followed by washing as prescribed in the PicoPure RNA Isolation kit user guide.
e) Eluted the RNA in 11 l elution buffer following the PicoPure protocol.

2. This RNA sample was directly used for amplification using the RiboAmp RNA Amplification Kit (Arcturus, Cat. # KIT0201). After two rounds of amplification, the aRNA was run on an agarose gel, and appeared as a smear, ranging from under 200 bases to over 600 bases in length (Figure 1B). The quality and quantity of aRNA after amplification were further examined by bioanalyzer (Agilent Technologies, Palo Alto, CA) (Figure 1C). Eight to ten micrograms (8-10 g) of aRNA was obtained from CapSure caps filled with microdissected cells, enough for quadruple hybridizations for each sample, using 2 g of aRNA per hybridization.

1. The aRNA was subjected to cDNA microarray analysis. Amplified RNA was labeled with Cy3 or Cy5 by direct incorporation of Cy3-dUTP or Cy5 dUTP in the reverse transcription reaction using random hexamer as primer. Labeled aRNA from IM and INTER sites were co-hybridized to TwinChip Mouse 6K cDNA chips (Digital Genomics Inc., Seoul, Korea) at 58C for 16 hours, then washed.

2. Four hybridizations were performed for each sample, including dye-swap, and microarrays were scanned using ScanArray Lite (Perkin Elmer, Billerica, MA). Scanned images were analyzed with GenePix software version 3.0 (Axon Instruments, Union City, CA) to obtain gene expression ratios. Data was then analyzed using Significance Analysis of Microarrays software program (SAM, Version 1.10) in a one-class response format. Abnormal data was flagged during GenePix software analysis and such numeric data was excluded from SAM analysis. Missing data were imputed using the average of 10 nearest neighbors.

The quantitated intensity data were transformed to M & A values by the following equation:

R is background-subtracted Cy5 (IM sample) intensity and G is background subtracted Cy3 (INTER sample) intensity. Transformed data were normalized using lowess function implemented in S-plus statistical software package. (User defined parameter f for LOWESS function was set at 0.2.) The normalized data were used for SAM analysis and clustering analysis.

3. Figure 2 shows the identification of the genes with significant changes in expression. The graph shows the scatter plot of the observed relative difference d(i) versus the expected relative difference dE(i). The red spots (right upper quadrant) indicate the genes with higher expression at IM, while the green spots (left lower quadrant) indicate the genes with higher expression at INTER sites. The microarray data were normalized with lowess and visualized by MA scatter plot (Figure. 3). The horizontal axis shows the A value representing the signal intensity and the vertical axis shows the M value representing the gene expression difference. Representatives from significant genes determined by SAM are indicated with black arrows. Some non-significant genes with high M values are marked with red arrows.

4. Figure 4 depicts two-dimensional cluster analysis of the data. Using the information from Gene Ontology Consortium (, we associated the genes selected by SAM with biological functions.

Results and Discussion
To identify the molecular basis for blastocyst implantation in the uterus, we compared RNA of luminal epithelium from IM and INTER sites. Pure luminal epithelium was is olated by LCM analysis (Fig. 1). Total RNA from the captured luminal epithelium was amplified and the differential gene expression between IM and INTER sites was examined by cDNA microarray analysis. Hybridizations were done in quadruplicate in a dye-swap manner, and the data were analyzed by using the significance analysis of microarrays (SAM). Figure 2 shows an identification of the genes with significant changes in expression. The graph shows the scatter plot of the observed relative difference d(i) versus the expected relative difference dE(i). The red spots (right upper area) indicate the genes with higher expression at IM, while the green spots (left lower area) indicate the genes with higher expression at INTER sites.

SAM is a statistical technique for the finding of significant genes in a set of microarray experiments. SAM uses repeated permutations of the data to determine if the expression of any gene is significantly related to the response variable (in this case, the difference between IM and INTER). In SAM, the relative difference d(i) for gene i is defined as:

where ri is a fold difference (or M value), si is a standard deviation, and s0 is a fudge factor. The expected relative difference dE(i) is the average of d(i)s from the data set generated by permutations. SAM calls a gene significant if the difference between d(i) and dE(i) is larger than user-provided threshold (delta value). For genes identified as significant, SAM estimates the percentage of genes identified by chance, the false discovery rate (FDR). For example, if 100 genes with 5% of FDR were selected, five genes among 100 genes are likely to be false positive.

In Figure 2, 88 genes were selected as significant in regard to gene expression changes with a FDR of 10%. Among them, 12 genes were negatively significant (green spots) and the rest were positively significant (red spot s). Because we used intensities from the IM sample in the numerator portion of gene expression ratio, the positively significant genes could be interpreted as up-regulated genes in IM samples.

The microarray data from quadruplet hybridizations for each sample were normalized with LOWESS and visualized by MA scatter plot (Fig. 3). The horizontal axis of Figure 3 (Mean of A) represents the signal intensity and the vertical axis (Mean of M) represents the gene expression difference. Representatives from significant genes determined by SAM were indicated with black arrow. Some non-significant genes with high M values were marked with red arrows.

Figure 4 depicts clustering visualization of our data. This figure is a pseudo-color representation of M values of 88 genes that were identified as significant in SAM analysis. The M value was color-coded according to its numeric value using Treeview software. The red color indicates up-regulated gene expression, while the green color indicates down-regulated gene expression.

Comparison by SAM revealed that 73 genes were more highly expressed at the IM site and 13 at the INTER site, showing higher expression within an estimated false discovery rate (FDR) of 0.163. These differentially expressed genes at each site were categorized based on the basis of the best available information regarding their biological functions. Among 73 highly expressed genes at the IM site, 6 were Expressed Sequence Tags (ESTs) and 14 were genes with unknown functions. The remaining 53 genes with known functions were categorized as being structural proteins (24, 45.3%) or as being related to metabolism (6, 11.3%), signal transduction (7, 13.2%), immune responsiveness action (6, 11.3%), cell cycling (4, 7.5%), gene/ protein expression (4, 7.5%), and oxidative stress (2, 3.8%). Meanwhile, among 13 genes that were up-regulated at the INTER site, 2 were ESTs and 6 were genes with unknown functions. The remaining set of 5 genes had functions relate d to metabolism (3), gene/protein expression (1), and signal transduction (1) (data not shown). Among those 58 genes with known functions and are expressed at both IM and INTER sites, 13 (22.4%) genes were associated with Ca2+ for their functions and/or regulations.

In the present study, we compared the gene expression profiles of the luminal epithelial endometrium of implantation (IM) and interimplantation (INTER) sites to elucidate the genes involved in the process of embryo apposition prior to implantation using LCM, linear amplification of RNA and microarray analysis. The nature of these genes suggest and that active tissue remodeling is in progress at the implantation sites before the embryonic attachment. Further, we propose that Ca2+ is a crucial regulatory factor, actively involved in this process. The list of genes identified may provide information regarding molecular mechanisms occurring at the implantation sites before embryo attachment and regulated by various embryonic factors.

1 Reese, J., Das, S.K., Paria, B.C., Lim, H., Song, H., Matsumoto, H., Knudtson, K.L., DuBois, R.N., Dey, S.K. (2001) Global gene expression analysis to identify molecular markers of uterine receptivity and embryo implantation. J Biol Chem, 276, 4413744145.

2 Carson, D.D., Lagow, E., Thathiah, A., Al-Shami, R., Farach-Carson, M.C., Vernon, M., Yuan, L., Fritz, M.A., Lessey, during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening. Mol Human Reprod, 8, 871-879.

3 Yoon, S.J., Choi, D.H., Lee, W.S., Cha, K.Y., Kim, S.N., Lee, K.A. (2004) A molecular basis for embryo apposition at the luminal epithelium. Mol Cell Endocrinol, 219, 95-104.

The data described herein has been published, in part, in Yoon et al., Mol Cell Endocrinol, 219: 95-104, (2004).

back to top


Page: All 1 2 3 4 5 6 7 8

Related biology technology :

1. Fractionating DNA Fragments Generated by Differential Display PCR
2. Identification of Differentially Expressed Gene Products with the CastAway System*
3. An Epitope Tagging Vector for Gene Expression in Mammalian Cells
4. Antibodies for Studying NMDA Receptor Protein Expression and Synapse-Specific Immunolabeling
5. High-Level Expression of Peanut Allergens Affected by Rare Codon Usage
6. Versatile Vectors for Ponasterone A- Inducible Control of Gene Expression in Mammalian Cells
7. Innovative Tissue Array Technology for High-Throughput Screening of Gene Expression
8. New Mammalian Expression Vectors Employ Stable, High-Level Fluorescence Humanized Renilla GFP Reporter
9. Functional Cloning Using ViraPort Retroviral cDNA Expression Libraries
10. High-Level Protein Expression, One-Column Purification, and FLAG Epitope Tagging in E. coli
11. A New Lambda Vector for Mammalian Expression
Post Your Comments:

(Date:3/23/2017)... Research and Markets has announced the ... to their offering. ... The Global Market for Bioproducts Should Reach ... a CAGR of 8.9%, This research report ... seven major product segments: bio-derived chemicals, biofuels, pharmaceuticals (biodrugs and ...
(Date:3/23/2017)... Colo. , March 23, 2017  GlobeImmune, Inc. ... agreement for the sale of 12,835,490 shares of its ... NantWorks  ecosystem of companies. In connection with the sale of ... $100,000 in cash and issue to GlobeImmune 200,000 shares, ... stock. "We are pleased to enter ...
(Date:3/23/2017)... SEATTLE , March 23, 2017 ... translational development of novel therapies in immuno-oncology, today ... to lead" small molecule compounds that activate interferon ... (RLR) pathways and demonstrate immune-mediated tumor regression in ... in the study who demonstrated complete tumor regression ...
(Date:3/23/2017)... Colo. , March 23, 2017  Agriculture technology ... Series A financing and note conversion to commercialize its ... Planet is focused on developing products that are simultaneously ... $30 million in the last 18 months. This latest ... North Bridge Venture Partners. The company,s ...
Breaking Biology Technology:
(Date:3/22/2017)... Vigilant Solutions , a vehicle location ... announced today the appointment of retired FBI special agent ... business development. Mr. Sheridan brings more than ... focus on the aviation transportation sector, to his new ... Sheridan served as the Aviation Liaison Agent Coordinator (ALAC) ...
(Date:3/13/2017)... Future of security: Biometric Face Matching software  ... ... DERMALOGs Face Matching enables to match face pictures against each other or against ... (PRNewsFoto/Dermalog Identification Systems) ... Matching" is the fastest software for biometric Face Matching on the market. The ...
(Date:3/7/2017)... March 7, 2017   HireVue , the leading ... companies identify the best talent, faster, today announced the ... Officer (CSO) and Diana Kucer as Chief ... seasoned executive team poised to drive continued growth in ... a year of record bookings in 2017. ...
Breaking Biology News(10 mins):